Alumend

Novel therapy will have room to grow at USD Discovery District

After two decades in development, a unique drug and device combination for a hard-to-treat disease will have a new home at the USD Discovery District.

12 months ago

Biopharmaceutical companies to locate at USD Discovery District

SAB Biotherapeutics and Alumend are the first companies to announce plans to locate at the USD Discovery District.

1 year ago

Companies to watch: These three biotech startups are in clinical trials

Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.

2 years ago

Groundbreaking Avera-backed therapy cleared for clinical trials

A technology to treat peripheral vascular disease that was developed in a Sioux Falls lab and acquired by Avera has been approved for clinical trials.

2 years ago

News Tip

Have a business news item to share with us?

Scroll to top